The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study
Anna Tomczak, May Han
Topics & Concepts
Neuromyelitis opticaMedicineSpectrum disorderMultiple sclerosisCoronavirus disease 2019 (COVID-19)AutoantibodyPandemicDiseasePopulationAquaporin 4PediatricsImmunologyPsychiatryInternal medicineAntibodyEnvironmental healthInfectious disease (medical specialty)Multiple Sclerosis Research StudiesCNS Lymphoma Diagnosis and TreatmentLong-Term Effects of COVID-19